Bora Pharmaceuticals Board Approves Buyback of 200,000 Shares for Employee Transfer

Bora Pharmaceuticals Co., Ltd. announced that its board of directors resolved on May 13, 2026 to repurchase common shares from the centralized securities exchange market for the purpose of transferring them to employees, aiming to incentivize staff and strengthen employee commitment. The planned repurchase period runs from May 14, 2026 to July 13, 2026. The company plans to buy back 200,000 shares, representing 0.16% of its total issued shares. The repurchase price range is NT00 to NT00 per share, and the company will continue the repurchase even if its share price falls below the lower end of the range. The maximum total amount available for the buyback is NT1,067,791,198. At the time of filing, the company already held 361,500 treasury shares. The company stated that the buyback will be conducted in accordance with the Securities and Exchange Act and the Regulations Governing Share Repurchase by Exchange-Listed and OTC-Listed Companies. The repurchased shares may be transferred to eligible employees in one or multiple installments within five years from the repurchase date under the company’s 2026 employee share transfer rules. Any shares not transferred within the period will be deemed unissued and cancelled through the legally required registration procedures. The board stated that it has considered the company’s financial condition and that the buyback will not affect capital maintenance, as the planned repurchase represents only 0.16% of issued shares and the maximum required amount accounts for 0.61% of current assets. The securities underwriter assessed that the NT00 to NT00 repurchase price range complies with applicable rules and is reasonable.